Renal transplantation
M Suthanthiran, TB Strom - New England Journal of Medicine, 1994 - Mass Medical Soc
M Suthanthiran, TB Strom
New England Journal of Medicine, 1994•Mass Medical SocRenal transplantation is the treatment of choice for patients with end-stage renal disease.
Better comprehension of the rejection response, improved preservation of organs, judicious
use of cyclosporine, the application of antilymphocyte agents for the prevention and
treatment of rejection, and specific protocols for the prevention and treatment of infection
have all contributed to the recent improvement in outcome after renal transplantation.
Immunobiology of Renal Transplantation The Anti-Allograft (Rejection) Response Renal …
Better comprehension of the rejection response, improved preservation of organs, judicious
use of cyclosporine, the application of antilymphocyte agents for the prevention and
treatment of rejection, and specific protocols for the prevention and treatment of infection
have all contributed to the recent improvement in outcome after renal transplantation.
Immunobiology of Renal Transplantation The Anti-Allograft (Rejection) Response Renal …
Renal transplantation is the treatment of choice for patients with end-stage renal disease. Better comprehension of the rejection response, improved preservation of organs, judicious use of cyclosporine, the application of antilymphocyte agents for the prevention and treatment of rejection, and specific protocols for the prevention and treatment of infection have all contributed to the recent improvement in outcome after renal transplantation.
Immunobiology of Renal Transplantation
The Anti-Allograft (Rejection) Response
Renal-allograft rejection depends on the coordinated activation of alloreactive T cells and antigen-presenting cells (e.g., monocyte-macrophages, dendritic cells, and B cells). Whereas acute rejection is a T-cell-dependent process, a broad array . . .
The New England Journal Of Medicine